Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (18 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Revenue
45
107
241
409
462
Gross Profit
17
0
0
0
0
Media costs
0
51
104
173
189
Other cost of revenue
27
9
22
49
80
Research and development
2
5
18
40
45
Sales and Marketing
17
41
83
146
166
General and administrative
2
8
29
61
58
Goodwill, Impairment Loss
0
0
0
0
118
Restructuring charges
0
0
0
0
7
Total costs and expenses
21
114
255
469
663
Operating loss
-4
-8
-15
-60
-202
Interest expense
0
0
1
3
5
Other (income) expense, net
0
0
0
5
3
Change in fair value of convertible preferred stock warrant liability
0
-2
-5
0
0
Total other expense, net
1
2
6
8
8
Loss before income taxes
-4
-10
-21
-69
-209
INCOME TAX PROVISION (BENEFIT)
0
0
0
-4
1
Net loss
-4
-10
-21
-64
-211
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
15
114
107
79
Accounts receivable, net
n/a
47
91
135
125
Prepaid expenses
n/a
1
2
4
4
Other current assets
n/a
0
4
13
2
Total current assets
n/a
64
211
259
209
Property, equipment and software, net
n/a
11
26
89
83
Restricted cash
n/a
0
0
3
2
Intangible assets
n/a
0
0
69
51
Goodwill
n/a
0
0
115
0
Deferred tax assets, net
n/a
0
0
2
1
Other assets
n/a
0
1
1
1
Total assets
n/a
75
238
539
347
Liabilities and owners' equity
Accounts payable
n/a
17 17482000
40 39910000
76 76085000
71 71292000
Accrued and other current liabilities
n/a
6 6186000
22 21584000
33 33258000
41 40734000
Deferred revenue
n/a
0 187000
1 918000
1 593000
2 2116000
Current portion of Capital Leases
n/a
0 0
0 203000
5 5482000
9 8602000
Current portion of debt
n/a
2 1988000
7 7243000
46 45705000
46 45720000
Total current liabilities
n/a
26 25843000
70 69858000
161 161123000
168 168464000
Debt - Less current portion
n/a
5 4978000
20 19568000
23 23335000
18 17617000
Capital leases—Less current portion
n/a
0 0
0 412000
12 12341000
12 11855000
Deferred rent—Less current portion
n/a
0 430000
4 3909000
27 26818000
14 14042000
Deferred tax liabilities
n/a
0 334000
0 207000
2 2068000
0 0
Convertible Preferred Stock Warrant Liability
n/a
3 2741000
0 0
0 0
0 0
Other liabilities
n/a
0 0
0 387000
1 814000
1 1176000
Total liabilities
n/a
34 34326000
94 94341000
226 226499000
213 213154000
Commitments and contingencies (Note 12)
n/a
0 0
0 0
0 0
0 0
Common stock, $0.001 par value— 1,000,000,000 authorized as of December 31, 2015 and 2014, respectively; 43,567,016 and 42,002,533 issued and outstanding as of December 31, 2015 an
n/a
0 8000
0 33000
0 42000
0 44000
Additional paid-in capital
n/a
4 3865000
188 187624000
422 421630000
453 453338000
Accumulated other comprehensive loss
n/a
0 -84000
0 -15000
0 -120000
0 -151000
Accumulated deficit
n/a
-24 -23543000
-44 -44475000
-109 -108786000
-319 -319331000
Total stockholders’ equity
n/a
41 40863000
143 143167000
313 312766000
134 133900000
Total liabilities and stockholders’ equity
n/a
75 75189000
238 237508000
539 539265000
347 347054000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Mar 14, 2016 n/a restated on May 10, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (48 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net loss
-4
-10
-21
-64
-211
Goodwill, Impairment Loss
0
0
0
0
118
Depreciation and amortization
2
4
8
24
51
Provision for doubtful accounts
0
0
0
0
0
Impairment of Leasehold
0
0
0
0
7
Stock-based compensation
0
3
11
24
26
Issuance of Restricted Stock
0
0
0
0
0
Amortization of debt discount
0
0
0
0
0
Deferred taxes
0
0
0
-5
0
Excess tax benefit from stock-based activity
0
0
0
0
0
Other non-cash adjustments, net
0
0
1
1
1
Change in fair value of preferred stock warrant liability
0
2
5
0
0
Accounts receivable
-10
-31
-44
-25
9
Prepaid expenses and other assets
0
-1
-5
-9
9
Other current assets
0
0
0
0
0
Other assets
0
0
0
0
0
Accounts payable
4
10
21
27
-4
Accrued and other liabilities
1
4
14
-1
0
Deferred rent
0
0
3
24
-3
Deferred revenue
0
0
1
0
2
Net cash provided by (used in) operating activities
-7
-19
-6
-6
4
Purchases of property, equipment and software
-2
-4
-14
-48
-12
Business acquisition, net
0
0
0
-97
0
Capitalized internal-use software development costs
-3
-5
-6
-8
-12
Changes in restricted cash
0
0
0
-2
1
Net cash used in investing activities
-5
-9
-20
-155
-24
Proceeds from the issuance of common stock in initial and follow-on public offering, net of underwriting discounts, commission and issuance costs
0
0
104
115
0
Issuance costs related to initial public offering
0
0
0
0
0
Proceeds from the issuance of convertible preferred stock, net of issuance costs
7
34
0
0
0
Proceeds from exercise of common stock options and common stock warrants
0
1
1
4
1
The cash inflow associated with the amount received from exercise of unvested common stock options.
0
0
0
0
0
Payments for Repurchase of Common Stock Options Exercised
0
0
0
0
0
Borrowings from line of credit
2
0
0
0
0
Excess tax benefit from stock-based activity
0
0
0
0
0
Proceeds from issuance of common stock from employee stock purchase plan
0
0
0
6
4
Tax withholdings related to net share settlements of restricted stock units
0
0
0
-1
-1
Repayment of capital lease obligations
0
0
0
-1
-6
Proceeds from debt facilities, net of debt issuance costs
0
9
47
44
0
Repayment of debt facilities
0
-6
-27
-14
-6
Net cash (used in) provided by financing activities
8
37
125
155
-9
Effect of exchange rate changes on cash and cash equivalents
0
0
0
0
0
Change in cash and cash equivalents
-3
10
99
-7
-28
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo